Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Urea + lactic acid is a topical combination used primarily as an emollient and keratolytic agent for the treatment of dry, rough, or scaly skin conditions such as eczema, psoriasis, ichthyosis, xerosis, and hyperkeratosis. Urea acts as a humectant and keratolytic by drawing moisture into the skin and breaking down hardened or scaly areas to facilitate exfoliation. Lactic acid is an alpha-hydroxy acid (AHA) that gently exfoliates the outermost layer of skin while also aiding in moisture retention. Together they synergistically hydrate the skin and promote smoother texture by removing dead cells from the surface[6][8]. This combination may also be used to treat certain nail disorders (e.g., ingrown nails) and has been studied for prevention of hand-foot syndrome in chemotherapy patients[4]. The product is generally well-tolerated but may cause mild local irritation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on urea + lactic acid.